Main content
Sorry, this episode is not currently available

AstraZeneca Committee

Live coverage of the Science and Technology Committee's session on the potential impact on UK science of a merger between AstraZeneca and Pfizer, with evidence from both companies and universities and science minister David Willetts.

2 hours, 15 minutes

Broadcast